PTPRC and inflammatory bowel disease: We therefore conducted separate analyses for CD45+CD3+ T cells (Fig 4) and CD45+ CD3− non‐T cells (Fig 5) within LPMCs of IBD patients and non‐inflamed controls using the gating strategy shown in Appendix Figs S7 and S8.